Nov./Dec. 2011

Online Investigator Training in Clinical Trials: A Roadmap For Success

November 11, 2011

A Roadmap for Success Successfully implementing online investigator training for clinical research sites requires technology and processes developed specifically for this purpose. As readers of this article are aware, research sites operate in a highly regulated and scrutinized environment. Sites also have a wide range of technical infrastructure and capabilities from study to study and […]

Enter the Age of the E-Reader

November 11, 2011

E-readers are the perfect device to deliver more engaging, emotionally ­ connecting, or richly informative content to patients in the form of an e-book, short story, newsletter, or e-magazine. Buddy Scalera, SVP, Interactive Content and Market Research,Ogilvy CommonHealth Interactive Marketing, part of Ogilvy CommonHealth Worldwide Carrie Baczewski, Copywriter, Ogilvy CommonHealth Interactive ­Marketing, part of Ogilvy […]

The Increasing Role of the Patient in Phase IV Studies and Registries

November 11, 2011

Even though Phase IV studies and patient registries have been increasingly required by regulatory agencies for several years now and a wide range of technologies exist to design and manage them in an efficient manner, life-science organizations are still struggling to effectively implement large real-world observational studies. Key challenges such as study design, study implementation, […]

E-Solutions: Not Just Another Pretty Face

November 11, 2011

J. Knipper and Company I was recently visiting a client who had just been given a demonstration of a Web-based shopping cart product. He had a medical device that he wanted to make available to doctors for online ordering and resale, so he had been reviewing various e-commerce solutions. He was very excited and wanted […]

Health Outcomes Research: An Evolution Towards Personalized Medicine and The Digital Future

November 11, 2011

Medicine and the Digital Future eResearchTechnology Inc. Health outcomes research has emerged as the science of measuring the benefits to patients of new medical products and empirically substantiating those benefits. The term “health-related quality of life” (HRQL) first began to appear in regulatory submissions for labeling and promotion of new pharmaceutical compounds in the mid-1990s. […]

Showcase Feature: Building a Better E-Machine

November 11, 2011

Carolyn Gretton Technological innovation remains essential to ensuring companies’ success in the data-driven Pharma 3.0 environment. According to Ernst & Young’s Progressions 2011 report, the next-generation pharma ecosystem continues to gain complexity, with initiatives expanding across a broader array of technologies, including a boom in health-related smartphone apps. IDC Health Insights’ biannual Leading Indicators in […]

Global: A Shrinking World

November 11, 2011

Taren Grom Global reach, emerging markets, and cross-divisional ­ expertise are playing an increasing role in all aspects of the life sciences, from R&D and clinical trials to sales and marketing. According to the IMS Institute for Healthcare Informatics, pharm­erging markets will approach U.S. levels of spending on medicines. Over the next five years, the […]

Sales: Sales Shift

November 11, 2011

As sales models continue to morph in light of resource realignment, analysts say the most successful companies will need to have a good talent management strategy in place and will need to provide sales training commensurate with the rep’s role in the future. The future of salesforces has been top of mind for some time […]

Patient Communities: The Emerging Role of Patient Communities

November 11, 2011

Social media serves up patient information to marketers.

Advertising: New Media Pushes Boundaries of Yesterday’s Advertising

November 11, 2011

Robin Robinson “Without question, new media has changed healthcare advertising campaigns. ” Drew Desjardins / Dudnyk New Media Pushes Boundaries of Yesterday’s Advertising Digital is here to stay and the advertising world, like everyone else, is feeling the impact. The impact of new media, including mobile, social networks, and digital capabilities, will change the shape […]

Publication Planning: The Future of Publication Planning is Bright

November 11, 2011

Robin Robinson The integrity of publication planning has taken some hits, but the new Sunshine Act can help restore credibility. The publication planning process, which has been fraught in past years with issues related to integrity, transparency, and trust, is still a key element in any marketing plan. Publications have suffered from a few missteps […]

Market Research: Tapping into New Market Research Opportunities

November 11, 2011

Tapping into New Market Research Opportunities The growing use of social media is creating new resources for researchers. “Segmentation of the future will be built on many ongoing threads of information and will be more focused on the alignment of the best product for the right ­patient. ” Scott Evangelista / Deloitte Social media is […]

PR Today: The Best of Times, The Worst of Times

November 11, 2011

With the litany of struggles the industry is facing every day, it is no wonder that the role of public relations in the marketing mix is more important than ever. “Through physician leaders and patient advocates, PR offers a unique opportunity to change ­customer thinking and behavior in a credible and cost-effective ­manner. ” Joe […]

Social Media: The Time has come to Run the Hurdles

November 11, 2011

In just a year, social media marketing has come a long way within the industry — in relative terms, that is. And in the coming year, more strides will be made. Pharma still lags behind other industries in its social media spend and use, but it has taken some baby steps in communicating with patients […]

Media Mix of the Future: Digital Channels and Unbranded Messaging

November 11, 2011

Consumer demand will force marketers to adopt the use of social media and targeted patient education as part of the marketing mix. The media and channel mix of tomorrow will begin to shift toward more digital, consumer-centric media, although in the early days, bottom-line channel decisions will still be based on ROI, our experts say. […]

R&D: The Drug Device Conundrum

November 11, 2011

Combining molecules with devices continues to be an evolving trend, but a lot of uncertainty exists around these combination products. There has been a movement toward convergence of technologies. More and more, drugs are being delivered or used in combination with a device with the intent to reduce side effects and increase efficacy. One of […]

R&D: Global Regulatory Oversight

November 11, 2011

Growing regulatory requirements, continued standardization of submission and data requirements, and a continued focus on safety are just a few of the issues facing pharmaceutical companies. “With the FDA’s recent ­acceptance into PIC/S, an ­international agreement between countries’ regulatory agencies, ­inspection information will now be shared between the agencies. ” KR Karu / Sparta Systems […]

R&D: Strategic Outsourcing

November 11, 2011

CROs and pharmaceutical companies continue to finetune their strategic partnerships to gain a competitive edge. “”Companies are looking at ­outsourcing models that allow for sharper research focus, enhanced quality, improved efficiency, and offer a lower and more flexible cost base. ” Alan Morgan / ICON Clinical Research “Going forward, we will see an increase in […]

Building a Culture of Innovation

November 11, 2011

Pharmaceutical R&D is under pressure to counter rising costs, depleted pipelines, and impending patent expiries. The industry is facing not only a productivity crisis, but also a crisis in innovation. Industry analysts say many pharmaceutical and biopharma companies are turning their focus away from R&D and innovation, yet a recent survey by Quintiles and the […]

The C-Suite: Corporate Strategies

November 11, 2011

New Ways Forward Experts agree the time has come to re-evaluate the overall working culture of the life-sciences industry, and they say innovation, new payer models, new stakeholders, and new outcomes are key considerations for future success. “Pharma will need to generate data that are timely, relevant, and robust to better gain the ­attention of […]

C-Suite: Executive Insights

November 11, 2011

CEOs, presidents, and executive management team members from across the industry — pharmaceutical, biotechnology, and service companies — discuss the most crucial factors driving change in the industry, as well as their strategies for meeting the challenges of business in the coming years. Jed Beitler is Chairman and CEO Worldwide of Sudler & Hennessey, a […]

What’s Ahead for 2012

November 11, 2011

Our readers identified the top trends and game changers they expect to define the various industry sectors in the coming year. John Blakeley Executive VP and Chief Commercial Officer ERT, a clinical research service provider that assesses the safety of newly developed drugs by major pharmaceutical companies. For more information, visit ert.com. I strongly believe […]

The Year of the Extreme Makeover

November 11, 2011

Every sector in the industry is in a state of flux. In this special issue of PharmaVOICE, more than 160 thought leaders throughout the life-sciences industry discuss the changing market dynamics. According to PricewaterhouseCooper’s 14th Annual Global CEO Survey, which looks at the concerns expressed by pharmaceutical and life-sciences company leaders, CEOs are most concerned […]

Last Word

November 11, 2011

Taking Digital Communications to the Next Level Jay Bolling, President and CEO of Roska Healthcare ­Advertising, provides his insights on the changing ­marketing landscape. PV: Last year, Roska took a bold step and was among the first healthcare agencies to use a QR code as part of a marketing campaign. How has the industry’s use […]

Talent Pool

November 11, 2011

Pharmaceutical POOL Percival BARRETTO-KO Astellas Realigns Executive Team Astellas US, the U.S. affiliate of Tokyo-based Astellas Pharma, has named Percival Barretto-Ko senior VP, corporate strategy and government affairs. Mr. Barretto-Ko was previously executive director, corporate strategy and communications at Astellas Pharma Europe. He earned an MBA from Yale School of Management and an M.S. from […]

PharmaTrax

November 11, 2011

Sales, marketing, And R&D?Trends affecting the healthcare industry Healthcare Reform Viewed as Mixed Blessing Trend: Consumers believe the success of healthcare reform is dependent on achieving cost ­reduction and quality improvement — two things that traditionally stand in opposition to each other, especially at a time when funding for government programs is in jeopardy. The […]

Tools of the Trade

November 11, 2011

New electronic and web-based applications, sites, and technologies Sermo Sponsorship Harnesses Power of Physician-Peer Communications Trend: With social media making it easier than ever for physicians to connect and discuss new ­treatment developments, life-sciences ­companies are seeking innovative and appropriate ways to ­become part of these conversations. Sermo Sponsorship is a portfolio of offerings from […]

Social Media

November 11, 2011

Social Media trends, regs, and apps Roche Diabetes Care Increases Social Media Presence Trendwatch: Developers of health services and devices turning to patient engagement Roche Diabetes Care uses multiple social media channels to engage ­patients Roche Diabetes Care, which develops blood glucose monitoring systems and provides diabetes management systems and services for the diabetic community, […]

What’s New

November 11, 2011

New healthcare-related products, services, and companies Grey Group Launches Grey Healthy People Trend: Delivering cross-platform, integrated marketing solutions across a broad spectrum of health, wellness, and lifestyle sectors ­continues to be a driving force within agencies. Grey Healthy People is a global next-generation health and wellness communications division that expands the traditional healthcare agency mandate […]

FEEDBACK